{"id":"CHEMBL1013","canonicalSmiles":"N[C@@H](C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(Cl)CC[C@H]12)c1ccccc1","inchiKey":"JAPHQRWPEGVNBT-UTUOFQBUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LORACARBEF","yearOfFirstApproval":1991,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Lorabid"],"synonyms":["LY-163892","Loracarbef","Loracarbef hydrate"],"crossReferences":{"Wikipedia":["Loracarbef"],"drugbank":["DB00447"],"chEBI":["47544"]},"childChemblIds":["CHEMBL1200610"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1991."}
{"id":"CHEMBL1025","canonicalSmiles":"CC(C)OP(=O)(F)OC(C)C","inchiKey":"MUCZHBLJLSDCSD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ISOFLUROPHATE","yearOfFirstApproval":1957,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Floropryl"],"synonyms":["Dyflos","Fluostigmine","Isoflurophate"],"crossReferences":{"PubChem":["144206196","50113285"],"Wikipedia":["Diisopropyl_fluorophosphate"],"drugbank":["DB00677"],"chEBI":["17941"]},"count":1,"approvedIndications":["EFO_0000516"],"linkedTargets":{"rows":["ENSG00000087085"],"count":1},"linkedDiseases":{"rows":["EFO_0000516"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1957 and is indicated for glaucoma."}
{"id":"CHEMBL1090644","canonicalSmiles":"NN[11C](=O)c1ccncc1","inchiKey":"QRXWMOHMRWLFEY-KWCOIAHCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Pyridine-4-Carbohydrazide","maximumClinicalTrialPhase":0,"parentId":"CHEMBL64","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pyridine-4-Carbohydrazide"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1097235","canonicalSmiles":"NS(=O)(=O)c1cc(-c2nn[nH]n2)c(NCc2cccs2)cc1Cl","inchiKey":"HMEDEBAJARCKCT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZOSEMIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Azosemide"],"crossReferences":{"PubChem":["144206352","170465933"],"Wikipedia":["Azosemide"],"drugbank":["DB08961"],"chEBI":["31248"]},"description":"Small molecule drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL1098060","canonicalSmiles":"Cn1nc(C(=O)O)c2c1-c1nc(Nc3ccccc3)ncc1CC2","inchiKey":"ZOBRPBVIEUWYJR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1098060","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08355"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1116","canonicalSmiles":"Cl.O=C(c1ccc(OCCN2CCCCC2)cc1)c1c(-c2ccc(O)cc2)sc2cc(O)ccc12","inchiKey":"BKXVVCILCIUCLG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"RALOXIFENE HYDROCHLORIDE","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL81","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Evirex","Evista","Optruma","Ostiral","Raloxifene hydrochloride","Razylan"],"synonyms":["Keoxifene hydrochloride","LY-156758","LY156758","Raloxifene hydrochloride"],"crossReferences":{"DailyMed":["raloxifene%20hydrochloride"],"PubChem":["144203806","144212686","170465341","26753259","26753260","50106949","50106950","56320710","56324093"],"chEBI":["50740"]},"count":2,"linkedTargets":{"rows":["ENSG00000140009"],"count":1},"linkedDiseases":{"rows":["MONDO_0007254","EFO_0000673","EFO_0000692","EFO_0005411"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1997 and has 2 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1174","canonicalSmiles":"N=C(N)NCCCC[C@@H]1NC(=O)CCSSC[C@@H](C(N)=O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CC(=O)O)NC(=O)CNC1=O","inchiKey":"CZKPOZZJODAYPZ-LROMGURASA-N","drugType":"Protein","blackBoxWarning":false,"name":"EPTIFIBATIDE","yearOfFirstApproval":1998,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Eptifibatide","Integrilin"],"synonyms":["Eptifibatide"],"crossReferences":{"DailyMed":["eptifibatide"],"PubChem":["144206056","170465043"],"Wikipedia":["Eptifibatide"],"chEBI":["291902"]},"childChemblIds":["CHEMBL4068311"],"count":10,"approvedIndications":["HP_0004419"],"linkedTargets":{"rows":["ENSG00000259207","ENSG00000005961"],"count":2},"linkedDiseases":{"rows":["HP_0002140","EFO_0006834","Orphanet_232","EFO_0001645","EFO_0000319","EFO_0004277","EFO_0003106","EFO_0008585","EFO_0000712","EFO_0008583","EFO_0000612","HP_0004419","EFO_0005672","EFO_0008586"],"count":14},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1998 and is indicated for recurrent thrombophlebitis and has 9 investigational indications."}
{"id":"CHEMBL119084","canonicalSmiles":"NS(=O)(=O)c1ccc(C(=O)NCCCCNCS)cc1","inchiKey":"XLYYIFIRODREFK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL119084","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04002"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1200411","canonicalSmiles":"CCCN(CCC)CCc1cccc2c1CC(=O)N2.Cl","inchiKey":"XDXHAEQXIBQUEZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"ROPINIROLE HYDROCHLORIDE","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL589","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Adartrel","Aimpart xl","Ipinnia xl","Ralnea xl","Raponer xl","Repinex xl","Requip","Requip xl","Ropilynz xl","Ropinirole hydrochloride","Spiroco xl"],"synonyms":["Ropinirole hydrochloride","SK&F 101468-A","SK&F-101468-A"],"crossReferences":{"DailyMed":["ropinirole%20hydrochloride"],"PubChem":["50107005"]},"count":1,"approvedIndications":["EFO_0002508"],"linkedTargets":{"rows":["ENSG00000069696","ENSG00000149295","ENSG00000151577"],"count":3},"linkedDiseases":{"rows":["EFO_0002508"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1997 and is indicated for parkinson's disease. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200633","canonicalSmiles":"CC[C@H](C)[C@H]1O[C@]2(CC[C@@H]1C)C[C@@H]1C[C@@H](C/C=C(\\C)[C@@H](O[C@H]3C[C@H](OC)[C@@H](O[C@H]4C[C@H](OC)[C@@H](O)[C@H](C)O4)[C@H](C)O3)[C@@H](C)/C=C/C=C3\\CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2.CO[C@H]1C[C@H](O[C@H]2[C@H](C)O[C@@H](O[C@@H]3/C(C)=C/C[C@@H]4C[C@@H](C[C@]5(CC[C@H](C)[C@@H](C(C)C)O5)O4)OC(=O)[C@@H]4C=C(C)[C@@H](O)[C@H]5OC/C(=C\\C=C\\[C@@H]3C)[C@@]45O)C[C@@H]2OC)O[C@@H](C)[C@@H]1O","inchiKey":"SPBDXSGPUHCETR-JFUDTMANSA-N","drugType":"Unknown","blackBoxWarning":false,"name":"IVERMECTIN","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cardomec","Eqvalan","Heartguard","Ivermectin","Ivomec","Mectizan","Sklice","Soolantra","Stromectol"],"synonyms":["CD-5024","CD5024","Ivermectin","Ivermectin component b1a","L 640471","L-640471","MK 933","MK-933"],"crossReferences":{"DailyMed":["ivermectin"],"DrugCentral":["3972"]},"count":15,"approvedIndications":["EFO_1000760","EFO_1001342"],"description":"Unknown drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and is indicated for rosacea and helminthiasis and has 13 investigational indications."}
{"id":"CHEMBL1200708","canonicalSmiles":"CC(C)NCC(O)COc1ccc(COCCOC(C)C)cc1.O=C(O)/C=C/C(=O)O","inchiKey":"RZPZLFIUFMNCLY-WLHGVMLRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BISOPROLOL FUMARATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL645","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Bisoprolol Fumarate","Zebeta"],"synonyms":["CL-297939"],"crossReferences":{"PubChem":["49648468"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1200725","canonicalSmiles":"Clc1ccc(C(Cn2ccnc2)OCc2csc3c(Cl)cccc23)c(Cl)c1.O=[N+]([O-])O","inchiKey":"HAAITRDZHUANGT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SERTACONAZOLE NITRATE","yearOfFirstApproval":2003,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201196","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dermofix","Ertaczo"],"synonyms":["FI 7056","FI-7056","Sertaconazole nitrate"],"crossReferences":{"DailyMed":["sertaconazole%20nitrate"],"PubChem":["144204269","56463153"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2003 and has 1 investigational indication."}
{"id":"CHEMBL1200787","canonicalSmiles":"CC(COc1ccccc1)N(CCCl)Cc1ccccc1.Cl","inchiKey":"VBCPVIWPDJVHAN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENOXYBENZAMINE HYDROCHLORIDE","yearOfFirstApproval":1953,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL753","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dibenyline","Dibenzyline","Phenoxybenzamine hydrochloride"],"synonyms":["Bensylyte hydrochloride","Phenoxybenzamine chloride","Phenoxybenzamine hydrochloride"],"crossReferences":{"DailyMed":["phenoxybenzamine%20hydrochloride"],"PubChem":["144208786","144213295","17389764","26747462","26752311","50105976","855636"],"chEBI":["8078"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1953."}
{"id":"CHEMBL1201037","canonicalSmiles":"Cl.NCCCC(N)(C(=O)O)C(F)F.O","inchiKey":"FJPAMFNRCFEGSD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EFLORNITHINE HYDROCHLORIDE","yearOfFirstApproval":1990,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL830","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ornidyl","Vaniqa"],"synonyms":["Dfmo hcl","Difluromethylornithine","Eflornithine hydrochloride","Eflornithine hydrochloride monohydrate","MDL 71,782 A","MDL-71782-A","MDL-71782A","NSC-270295","NSC-337250","RMI-71782-A"],"crossReferences":{"DailyMed":["eflornithine%20hydrochloride"]},"count":3,"linkedTargets":{"rows":["ENSG00000115758"],"count":1},"linkedDiseases":{"rows":["Orphanet_733","EFO_0000502","EFO_0000621"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1990 and has 3 investigational indications."}
{"id":"CHEMBL1201168","canonicalSmiles":"Cc1cc(C(=O)NNCc2ccccc2)no1","inchiKey":"XKFPYPQQHFEXRZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"ISOCARBOXAZID","yearOfFirstApproval":1959,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Marplan"],"synonyms":["Isocarboxazid","NSC-169893","RO 5-0831","RO-5-0831"],"crossReferences":{"DailyMed":["isocarboxazid"],"PubChem":["11112152","144203887","56463226"],"Wikipedia":["Isocarboxazid"],"drugbank":["DB01247"]},"count":2,"approvedIndications":["EFO_0003761"],"linkedTargets":{"rows":["ENSG00000189221","ENSG00000069535"],"count":2},"linkedDiseases":{"rows":["EFO_0000249","EFO_0003761"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1959 and is indicated for unipolar depression and has 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201195","canonicalSmiles":"CO[C@@]1(NC(=O)CSCC#N)C(=O)N2C(C(=O)O)=C(CSc3nnnn3C)CS[C@@H]21","inchiKey":"SNBUBQHDYVFSQF-HIFRSBDPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFMETAZOLE","yearOfFirstApproval":1989,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Cefmetazole","U-72791"],"crossReferences":{"PubChem":["90341375"],"Wikipedia":["Cefmetazole"],"drugbank":["DB00274"],"chEBI":["3489"]},"childChemblIds":["CHEMBL1201118"],"count":3,"approvedIndications":["EFO_0000771"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1989 and is indicated for bacterial disease and has 2 investigational indications."}
{"id":"CHEMBL1201212","canonicalSmiles":"COc1ccc(OC)c(C(O)CNC(=O)CN)c1","inchiKey":"PTKSEFOSCHHMPD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"MIDODRINE","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Midodrine","ST 1085","ST-1085"],"crossReferences":{"DailyMed":["midodrine%20hydrochloride"],"drugbank":["DB00211"],"chEBI":["6933"]},"childChemblIds":["CHEMBL1200461"],"count":6,"approvedIndications":["EFO_0000319"],"linkedTargets":{"rows":["ENSG00000171873","ENSG00000170214","ENSG00000120907"],"count":3},"linkedDiseases":{"rows":["HP_0100806","HP_0002140","EFO_0006834","EFO_1001346","EFO_0000712","EFO_0005252","EFO_1001919","EFO_1001488","EFO_0000319","EFO_0005251","HP_0001541"],"count":11},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and is indicated for cardiovascular disease and has 5 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201251","canonicalSmiles":"Oc1ccc(CCCCNC[C@H](O)c2ccc(O)c(O)c2)cc1","inchiKey":"IIRWWTKISYTTBL-SFHVURJKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ARBUTAMINE","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Arbutamine"],"crossReferences":{"Wikipedia":["Arbutamine"],"drugbank":["DB01102"],"chEBI":["50580"]},"childChemblIds":["CHEMBL1200385"],"count":1,"approvedIndications":["EFO_0000319"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1997 and is indicated for cardiovascular disease."}
{"id":"CHEMBL1201515","drugType":"Protein","blackBoxWarning":false,"name":"PEGVISOMANT","yearOfFirstApproval":2003,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Somavert"],"synonyms":["B-2036-PEG","B2036-PEG","Pegvisomant"],"crossReferences":{"DailyMed":["pegvisomant"],"DrugCentral":["5015"],"Wikipedia":["Pegvisomant"]},"count":7,"approvedIndications":["EFO_1001485"],"linkedTargets":{"rows":["ENSG00000112964"],"count":1},"linkedDiseases":{"rows":["EFO_0003869","EFO_0009607","EFO_1001485","Orphanet_93276","MONDO_0021117","EFO_0004142","EFO_0000673","EFO_0001073","EFO_0000691"],"count":9},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2003 and is indicated for acromegaly and has 6 investigational indications."}
{"id":"CHEMBL1201630","drugType":"Protein","blackBoxWarning":false,"name":"INSULIN PURIFIED PORK","yearOfFirstApproval":1979,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Iletin ii","Regular iletin ii (pork)","Regular purified pork insulin","Velosulin"],"synonyms":["Insulin (pork)","Insulin purified pork"],"count":1,"approvedIndications":["EFO_0000400"],"linkedTargets":{"rows":["ENSG00000171105"],"count":1},"linkedDiseases":{"rows":["EFO_0000400"],"count":1},"description":"Protein drug with a maximum clinical trial phase of IV that was first approved in 1979 and is indicated for diabetes mellitus."}
{"id":"CHEMBL1201640","drugType":"Protein","blackBoxWarning":false,"name":"INSULIN ZINC SUSP EXTENDED BEEF","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ultralente insulin"],"synonyms":["Insulin zinc susp extended beef"],"description":"Protein drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1201735","canonicalSmiles":"Br.CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1","inchiKey":"WSTCENNATOVXKQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"BUPROPION HYDROBROMIDE","yearOfFirstApproval":2008,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL894","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aplenzin"],"synonyms":["BVF-033","Bupropion hydrobromide"],"crossReferences":{"DailyMed":["bupropion%20hydrobromide"]},"count":1,"approvedIndications":["EFO_0003761"],"linkedTargets":{"rows":["ENSG00000103546","ENSG00000142319"],"count":2},"linkedDiseases":{"rows":["MONDO_0002009","EFO_0003768","EFO_0003761"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2008 and is indicated for unipolar depression. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1215923","canonicalSmiles":"O=C(O)Cc1cccc(-c2cc(CCCCCCc3ccc(O[C@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]4O)c(-c4cccc(CC(=O)O)c4)c3)ccc2O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]2O)c1","inchiKey":"RYWCQJDEHXJHRI-XJMXIVSISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BIMOSIAMOSE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bimosiamose","TBC-1269"],"crossReferences":{"PubChem":["124894548","144206811"],"drugbank":["DB06197"]},"childChemblIds":["CHEMBL2146099"],"count":2,"linkedTargets":{"rows":["ENSG00000188404","ENSG00000174175","ENSG00000007908"],"count":3},"linkedDiseases":{"rows":["EFO_0000676","EFO_0000341"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1229851","canonicalSmiles":"CC(C)CCC(=O)N1CCC[C@H]1C(=O)NCc1ccc(C(=N)N)cc1","inchiKey":"AEKJCSNKYXWOAQ-INIZCTEOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1229851","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06936"]},"childChemblIds":["CHEMBL3423005"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1230245","canonicalSmiles":"C[C@H](O)[C@H](O)[C@H]1CNc2nc(N)nc(N)c2N1","inchiKey":"NDSDGUULXHNXGA-RPDRRWSUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RONOPTERIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ronopterin","VAS-203","VAS203","Vas203"],"crossReferences":{"drugbank":["DB12575"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1230806","canonicalSmiles":"N[C@H]1C=C(CO)[C@@H](O)[C@H](O)[C@H]1O","inchiKey":"XPHOBMULWMGEBA-VZFHVOOUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VALIENAMINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Valienamine"],"crossReferences":{"Wikipedia":["Valienamine"],"drugbank":["DB02120"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1231013","canonicalSmiles":"Cc1cccc(C[C@H](N)C(=O)O)c1","inchiKey":"JZRBSTONIYRNRI-VIFPVBQESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1231013","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02685"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1231377","canonicalSmiles":"Cc1ccc2c(c1)N=C1N(c3ccccc3)CC[C@@]1(O)C2=O","inchiKey":"KAJFGRLMKVNMLH-GOSISDBHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1231377","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07469"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1231689","canonicalSmiles":"COc1cc(C)c(S(=O)(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](Cc2ccc(C(=N)N)cc2)C(=O)N2CCCCC2)c(C)c1C","inchiKey":"ZOXOKTJHZSUHRJ-XZOQPEGZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1231689","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03081"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1233973","canonicalSmiles":"CCCCCCCCCCCC[N+](C)(C)[O-]","inchiKey":"SYELZBGXAIXKHU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Lauryldimethylamine N-Oxide","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Lauryldimethylamine N-Oxide"],"crossReferences":{"PubChem":["26757705"],"drugbank":["DB04147"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL125278","canonicalSmiles":"NC(=O)O","inchiKey":"KXDHJXZQYSOELW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CARBAMIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Carbamic Acid"],"crossReferences":{"Wikipedia":["Carbamic_acid"],"drugbank":["DB04261"],"chEBI":["28616"]},"childChemblIds":["CHEMBL3560381"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1256958","canonicalSmiles":"CNC[C@H](O)c1ccc(O)c(O)c1.O=C(O)C(O)C(O)C(=O)O","inchiKey":"YLXIPWWIOISBDD-FVGYRXGTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EPINEPHRINE BITARTRATE","yearOfFirstApproval":1965,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL679","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bronitin","Bronitin mist","Medihaler-epi"],"synonyms":["(-)-Epinephrine Bitartrate","Adrenaline bitartrate","Epinephrine bitartrate"],"crossReferences":{"DailyMed":["epinephrine%20bitartrate"],"PubChem":["11532860","50106283"]},"count":1,"approvedIndications":["EFO_0003843"],"linkedTargets":{"rows":["ENSG00000184160","ENSG00000274286","ENSG00000169252","ENSG00000171873","ENSG00000170214","ENSG00000120907","ENSG00000043591","ENSG00000188778","ENSG00000150594"],"count":9},"linkedDiseases":{"rows":["EFO_0003843"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1965 and is indicated for pain."}
{"id":"CHEMBL1278146","canonicalSmiles":"CCN(CC)CCN1CCc2[nH]c(/C=C3\\C(=O)Nc4ccc(F)cc43)c(C)c2C1=O","inchiKey":"GKEYKDOLBLYGRB-LGMDPLHJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FAMITINIB","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SHR-1020"],"crossReferences":{"drugbank":["DB11741"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL131","canonicalSmiles":"C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO","inchiKey":"OIGNJSKKLXVSLS-VWUMJDOOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PREDNISOLONE","yearOfFirstApproval":1955,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cortalone","Dekotil","Delta-cortef","Deltacortril","Deltalone","Dilacort","Fernisolone-p","Hydeltra","Meti-derm","Meticortelone","Pevanti","Precortisyl","Precortisyl fte","Prednisolone","Prelone","Scheriproct","Servisone","Sterane"],"synonyms":["Desowen","Hydeltra-Tba","Meticortelone","NSC-9120","NSC-9900","Neo-Delta-Cortef","Poly-Pred","Pred-G","Prednisolone","Servisone","Tridesilon","Verdeso"],"crossReferences":{"DailyMed":["prednisolone"],"PubChem":["144204880","144208871","144213304","170464732","50085972"],"Wikipedia":["Prednisolone"],"drugbank":["DB00860"],"chEBI":["8378"]},"count":132,"approvedIndications":["EFO_0000729","EFO_0004274","EFO_0005558","EFO_0008997","EFO_0000565","EFO_0009456","EFO_0007520","EFO_0002506","EFO_0002690","EFO_0004255","EFO_0000676","EFO_0009552","HP_0003072","EFO_0005854","EFO_0009449","EFO_1000039","HP_0001742","HP_0001873","EFO_0000384","EFO_1001119","EFO_1000049","Orphanet_90794","EFO_0000270","EFO_0000398","EFO_0000574","EFO_1001051","HP_0012424","EFO_1001887","EFO_1001896","EFO_0007405","EFO_1001205","EFO_0005319","EFO_1000997","EFO_1000764","MONDO_0001280","EFO_1001435","HP_0001094","EFO_0003778","EFO_1000684","EFO_0000274","HP_0001915","HP_0004398","EFO_1000694","EFO_0005752","EFO_0009609","Orphanet_797","EFO_0000685","MONDO_0015128","EFO_0003898","EFO_1000941","EFO_0002609","EFO_0003106","EFO_0003885","EFO_0007257","EFO_0007403","EFO_1001194","EFO_0007141"],"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["EFO_0005539","EFO_0004190","EFO_0000756","EFO_1001345","EFO_0005952","HP_0004798","Orphanet_141127","HP_0011950","EFO_1001077","EFO_0000096","EFO_0002690","EFO_0003884","EFO_0000676","EFO_0004616","EFO_0008517","HP_0003072","EFO_0009449","HP_0000964","EFO_0007537","HP_0001742","EFO_0000384","MONDO_0008315","EFO_0000660","EFO_0001663","MONDO_0020290","EFO_0003032","EFO_1000391","EFO_1000049","EFO_0000574","EFO_0000341","EFO_0001378","EFO_0001054","EFO_0000516","EFO_1001887","EFO_0003086","EFO_1001896","EFO_0007405","EFO_1001205","EFO_0001365","EFO_1000997","MONDO_0007254","EFO_0000255","HP_0010450","MONDO_0016236","EFO_1000684","HP_0004448","MONDO_0003541","EFO_1000694","Orphanet_3451","EFO_0004289","EFO_0007208","EFO_0004826","EFO_0000183","MONDO_0002083","EFO_0005752","Orphanet_797","EFO_0000280","EFO_0003898","EFO_0000403","EFO_0000222","EFO_0003843","HP_0002315","EFO_1000954","EFO_0003885","EFO_0007257","EFO_0001060","EFO_0005297","EFO_0000764","EFO_1001194","EFO_1001373","MONDO_0018906","EFO_0007141","EFO_0007167","MONDO_0024880","EFO_0003956","EFO_0000729","MONDO_0000873","EFO_1001139","EFO_1001069","Orphanet_309015","EFO_0004274","EFO_0005558","EFO_1001110","EFO_0008997","EFO_0000565","EFO_0007160","EFO_0009456","EFO_0007520","EFO_0002506","MONDO_0019088","EFO_0000182","EFO_0004255","MONDO_0015540","EFO_0009552","EFO_1000749","EFO_0000692","EFO_0005854","EFO_0000759","EFO_0005761","EFO_0000220","EFO_1000039","EFO_0004236","EFO_0004194","HP_0001873","EFO_1000784","EFO_1001119","Orphanet_418","EFO_0004239","Orphanet_98896","HP_0100806","EFO_1001209","MP_0001845","MONDO_0001208","EFO_0000398","Orphanet_90794","EFO_0000270","EFO_1001051","HP_0012424","EFO_0001360","EFO_0003785","EFO_0007415","Orphanet_30391","EFO_0001059","MONDO_0003005","EFO_0005319","EFO_1000764","EFO_0000768","EFO_1001435","EFO_1001020","MONDO_0001280","EFO_0003778","HP_0001094","EFO_0000274","MONDO_0002462","EFO_0000209","EFO_1001888","HP_0001915","EFO_1001264","EFO_0009715","EFO_0004246","HP_0004398","HP_0000083","EFO_0008518","EFO_0000474","EFO_0004254","EFO_0000673","EFO_0003938","MONDO_0020743","EFO_0007427","EFO_1000726","EFO_0000717","EFO_1000635","EFO_0009609","EFO_0000685","MONDO_0015128","EFO_0000545","HP_0002140","EFO_0007140","EFO_1001321","EFO_1000941","EFO_0004237","EFO_0002609","EFO_0000311","MONDO_0001705","EFO_0003106","EFO_0000211","EFO_0007227","EFO_0007403","EFO_0007387","EFO_1001467","EFO_0003918"],"count":171},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1955 and has 57 approved and 75 investigational indications."}
{"id":"CHEMBL1387","canonicalSmiles":"C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C","inchiKey":"ICTXHFFSOAJUMG-SLHNCBLASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NORETHYNODREL","yearOfFirstApproval":1961,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Norethynodrel","Noretynodrel","SC-4642"],"crossReferences":{"PubChem":["11533052","144203910"],"Wikipedia":["Norethynodrel"],"drugbank":["DB09371"],"chEBI":["34895"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1961."}
{"id":"CHEMBL1431","canonicalSmiles":"CN(C)C(=N)NC(=N)N","inchiKey":"XZWYZXLIPXDOLR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"METFORMIN","yearOfFirstApproval":1995,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["LA-6023","Metformin"],"crossReferences":{"DailyMed":["metformin%20hydrochloride"],"PubChem":["11112469","137275802","144212687","174006543"],"TG-GATEs":["53"],"Wikipedia":["Metformin"],"drugbank":["DB00331"],"chEBI":["6801"]},"childChemblIds":["CHEMBL3094198","CHEMBL1703"],"count":114,"approvedIndications":["EFO_0000400"],"linkedTargets":{"rows":["ENSG00000178127","ENSG00000186010","ENSG00000137806","ENSG00000267855","ENSG00000119421","ENSG00000166136","ENSG00000198695","ENSG00000198840","ENSG00000184983","ENSG00000158864","ENSG00000168653","ENSG00000184752","ENSG00000099795","ENSG00000164258","ENSG00000065518","ENSG00000147684","ENSG00000131495","ENSG00000109390","ENSG00000170906","ENSG00000151366","ENSG00000004779","ENSG00000165264","ENSG00000198886","ENSG00000115159","ENSG00000145494","ENSG00000125356","ENSG00000123545","ENSG00000090266","ENSG00000128609","ENSG00000119013","ENSG00000198763","ENSG00000174886","ENSG00000140990","ENSG00000213619","ENSG00000189043","ENSG00000178057","ENSG00000160194","ENSG00000164182","ENSG00000136521","ENSG00000167792","ENSG00000115286","ENSG00000139180","ENSG00000023228","ENSG00000185633","ENSG00000183648","ENSG00000130414","ENSG00000110717","ENSG00000147123","ENSG00000212907","ENSG00000198786","ENSG00000198888"],"count":51},"linkedDiseases":{"rows":["EFO_1000419","EFO_0001361","EFO_0000365","EFO_1000710","EFO_0000275","EFO_0008569","EFO_0000756","EFO_1001390","EFO_0000308","MONDO_0044704","EFO_1001951","EFO_0003914","HP_0100543","EFO_1001492","EFO_0003931","EFO_1001459","EFO_0002690","MONDO_0002974","MONDO_0008903","EFO_0003884","EFO_0000676","Orphanet_827","EFO_1001348","HP_0002910","EFO_0000400","MONDO_0001941","HP_0000842","EFO_0005762","EFO_0002618","EFO_0005922","EFO_1000782","EFO_1001496","EFO_0000660","MONDO_0008315","EFO_0001663","MONDO_0002691","GO_0007568","EFO_0000341","EFO_0001378","EFO_0004364","HP_0001249","EFO_0009637","EFO_0004214","Orphanet_84","EFO_1001465","MONDO_0007254","Orphanet_98473","EFO_0003847","MONDO_0002158","EFO_0000289","MONDO_0002050","EFO_0003968","EFO_0000196","EFO_0000707","EFO_0002546","HP_0001541","HP_0012115","EFO_0000616","EFO_0000280","EFO_0000694","EFO_0006859","EFO_0001645","EFO_0000403","EFO_0000319","EFO_0001073","EFO_0000537","EFO_1000954","MONDO_0021350","EFO_0000195","EFO_0003885","EFO_0004220","EFO_1001892","EFO_0010269","EFO_0002614","EFO_1001121","EFO_0000764","EFO_0000649","MONDO_0011962","EFO_0000199","EFO_0000702","EFO_0002517","EFO_1001207","MONDO_0018906","EFO_0005411","EFO_0000519","EFO_0004265","Orphanet_524","HP_0001397","EFO_0001075","EFO_0003095","MONDO_0002009","EFO_0000571","HP_0001268","EFO_1000657","MONDO_0004222","EFO_0000228","EFO_1000235","EFO_0004593","Orphanet_733","EFO_0000182","HP_0003419","EFO_0003940","EFO_0000692","EFO_1000045","EFO_0001416","EFO_0005761","Orphanet_100","MONDO_0004658","HP_0003124","EFO_0000466","Orphanet_325546","EFO_0002687","EFO_0000220","MONDO_0008170","EFO_0003821","EFO_0009516","MONDO_0000396","Orphanet_309005","Orphanet_98896","MP_0001845","MONDO_0100096","EFO_0005537","EFO_0001359","EFO_0000233","EFO_0001360","Orphanet_282","EFO_0004566","Orphanet_232","EFO_1001901","MONDO_0015686","EFO_1001249","EFO_1001461","MONDO_0021063","EFO_0003876","MONDO_0002087","EFO_0000305","EFO_1000357","MONDO_0001187","EFO_0002950","EFO_1001480","EFO_1000044","MONDO_0041161","EFO_1000043","EFO_0003144","EFO_0000673","EFO_1000660","EFO_0003047","EFO_0002617","EFO_0000685","EFO_0000545","EFO_0003963","EFO_0000677","HP_0011015","EFO_0003770","EFO_0000313","Orphanet_110","EFO_0003060","Orphanet_908","EFO_0000311","EFO_0000589","EFO_0003863","EFO_0000095","MONDO_0004782","EFO_0001421","EFO_0004142","EFO_0003833","EFO_0003918","EFO_0000181","EFO_0003050"],"count":169},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1995 and is indicated for diabetes mellitus and has 113 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1434513","canonicalSmiles":"NC[C@H](O)c1ccc(O)c(O)c1.O.O=C(O)C(O)C(O)C(=O)O","inchiKey":"LNBCGLZYLJMGKP-JZGIKJSDSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"NOREPINEPHRINE BITARTRATE","yearOfFirstApproval":1950,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1437","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Adrenor","Aktamin","Levarterenol Bitartrate","Levophed","Noradrenaline","Norepinephrine bitartrate"],"synonyms":["Levarterenol bitartrate","NSC-169106","Noradrenaline","Noradrenaline bitartrate","Norepinephrine","Norepinephrine bitartrate","Norepinephrine bitartrate monohydrate","Norepinephrine d-bitartrate","Norepinephrine hydrochloride"],"crossReferences":{"DailyMed":["norepinephrine%20bitartrate"],"PubChem":["56463315"]},"count":4,"approvedIndications":["HP_0100806"],"linkedTargets":{"rows":["ENSG00000184160","ENSG00000274286","ENSG00000169252","ENSG00000171873","ENSG00000170214","ENSG00000120907","ENSG00000043591","ENSG00000188778","ENSG00000150594"],"count":9},"linkedDiseases":{"rows":["EFO_0004610","HP_0100806","HP_0000083","HP_0002140","EFO_0000319","EFO_0005251"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1950 and is indicated for sepsis and has 3 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1437585","canonicalSmiles":"Cc1ccc(C(=O)c2ccc(CC(=O)[O-])n2C)cc1.O.O.[Na+]","inchiKey":"QQILXENAYPUNEA-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1437585","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1020","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["11113045","144204343","170465216"],"chEBI":["72014"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1481873","canonicalSmiles":"COP(=S)(OC)SCN1C(=O)c2ccccc2C1=O","inchiKey":"LMNZTLDVJIUSHT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHOSMET","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Phosmet"],"crossReferences":{"PubChem":["144204544","144209514","144210413","170466810","50085458","7974290","84986995"],"drugbank":["DB11448"],"chEBI":["38786"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1531134","canonicalSmiles":"CC1CCN(CCCC(=O)c2ccc(F)cc2)CC1","inchiKey":"DKMFBWQBDIGMHM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MELPERONE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["FG 5111","FG-5111","Flubuperone","Melperone"],"crossReferences":{"PubChem":["144206136","170466288","50112880"],"drugbank":["DB09224"]},"childChemblIds":["CHEMBL4551527"],"count":5,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL1551899","canonicalSmiles":"CCN1CCN(C(=O)N[C@@H](C(=O)N[C@@H]2C(=O)N3C(C(=O)O)=C(CSc4nnnn4C)CS[C@H]23)c2ccc(O)cc2)C(=O)C1=O.O","inchiKey":"HRRMBILIWABKRK-WERGMSTESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1551899","maximumClinicalTrialPhase":0,"parentId":"CHEMBL507674","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["56463025"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1630578","canonicalSmiles":"C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)C3=CC[C@]2(C)[C@H]1C(=O)CN1CCN(c2cc(N3CCCC3)nc(N3CCCC3)n2)CC1","inchiKey":"RBKASMJPSJDQKY-RBFSKHHSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TIRILAZAD","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tirilazad","U 74006","U-74006"],"crossReferences":{"Wikipedia":["Tirilazad"],"drugbank":["DB13050"]},"childChemblIds":["CHEMBL3989513"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL16498","canonicalSmiles":"C=C1C[C@H]2C=Nc3cc(OCCCOc4cc5c(cc4OC)C(=O)N4CC(=C)C[C@H]4C=N5)c(OC)cc3C(=O)N2C1","inchiKey":"RWZVMMQNDHPRQD-SFTDATJTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SJG-136","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BN-2629","NSC-694501","SG-2000","SJG-136","SP-2001","Sjg 136","Sjg-136","UP-2001"],"crossReferences":{"PubChem":["524417"],"drugbank":["DB11965"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL166863","canonicalSmiles":"CC1(C)OC(c2ccc(S(N)(=O)=O)cc2)=C(c2cccc(F)c2)C1=O","inchiKey":"IJWPAFMIFNSIGD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"POLMACOXIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CG-100649","CG100649","Polmacoxib"],"crossReferences":{"drugbank":["DB12399"]},"count":4,"linkedTargets":{"rows":["ENSG00000133742","ENSG00000073756","ENSG00000104267"],"count":3},"linkedDiseases":{"rows":["EFO_0002506","EFO_1000786","EFO_0004616","EFO_0005755"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL1672054","canonicalSmiles":"CC(=O)N1CCN([C@H]2CCN(C(=O)N(C)[C@H](C)c3cc(C(F)(F)F)cc(C(F)(F)F)c3)[C@@H](c3ccc(F)cc3C)C2)CC1","inchiKey":"XGGTZCKQRWXCHW-WMTVXVAQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CASOPITANT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Rezonic","Zunrisa"],"synonyms":["Casopitant","GW-679769","GW679769","Gw679769"],"crossReferences":{"drugbank":["DB06634"]},"childChemblIds":["CHEMBL3542382","CHEMBL2107320"],"count":9,"linkedTargets":{"rows":["ENSG00000115353"],"count":1},"linkedDiseases":{"rows":["EFO_0006911","MONDO_0002009","HP_0002017","EFO_0004888","EFO_1000781","HP_0002013","EFO_0004698","HP_0002018","EFO_0008533"],"count":9},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 9 investigational indications."}
{"id":"CHEMBL1703","canonicalSmiles":"CN(C)C(=N)N=C(N)N.Cl","inchiKey":"OETHQSJEHLVLGH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"METFORMIN HYDROCHLORIDE","yearOfFirstApproval":1995,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1431","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bolamyn sr","Diagemet xl","Fortamet","Glucamet 500","Glucamet 850","Glucient sr","Glucophage","Glucophage sr","Glucophage xr","Glumetza","Glyformin","Janumet","Ledermetin","Metabet sr","Metformin hydrochloride","Metsol","Milform","Orabet","Riomet","Riomet er","Sukkarto sr"],"synonyms":["EX-404","EX404","LA-6023","Metformin hydrochloride","NSC-91485"],"crossReferences":{"DailyMed":["metformin%20hydrochloride"],"PubChem":["11532867","144204049","170464804","26749076","85273756"],"chEBI":["6802"]},"count":30,"approvedIndications":["EFO_0001360","EFO_0000400"],"linkedTargets":{"rows":["ENSG00000178127","ENSG00000186010","ENSG00000137806","ENSG00000267855","ENSG00000119421","ENSG00000166136","ENSG00000198695","ENSG00000198840","ENSG00000184983","ENSG00000158864","ENSG00000168653","ENSG00000184752","ENSG00000099795","ENSG00000164258","ENSG00000065518","ENSG00000151366","ENSG00000131495","ENSG00000170906","ENSG00000109390","ENSG00000147684","ENSG00000004779","ENSG00000165264","ENSG00000198886","ENSG00000115159","ENSG00000145494","ENSG00000125356","ENSG00000123545","ENSG00000090266","ENSG00000128609","ENSG00000119013","ENSG00000198763","ENSG00000174886","ENSG00000140990","ENSG00000213619","ENSG00000189043","ENSG00000178057","ENSG00000160194","ENSG00000164182","ENSG00000136521","ENSG00000167792","ENSG00000115286","ENSG00000139180","ENSG00000023228","ENSG00000185633","ENSG00000183648","ENSG00000130414","ENSG00000110717","ENSG00000212907","ENSG00000147123","ENSG00000198786","ENSG00000198888"],"count":51},"linkedDiseases":{"rows":["Orphanet_84","EFO_1000419","HP_0001397","EFO_0000571","EFO_1001465","MONDO_0007254","MONDO_0004222","MONDO_0021063","MONDO_0002087","EFO_1000235","EFO_1000357","EFO_1000044","EFO_0004593","EFO_1001459","EFO_1000043","MONDO_0002158","EFO_0003144","EFO_0003884","EFO_0000673","Orphanet_827","EFO_0000400","HP_0000842","HP_0001541","EFO_0002618","EFO_0006859","EFO_0000466","EFO_0001073","MONDO_0008315","EFO_0000660","EFO_0003060","EFO_0001663","EFO_0000195","MP_0001845","EFO_1001121","EFO_0002517","EFO_0000199","EFO_0001378","EFO_0001360","EFO_0009637"],"count":39},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1995 and is indicated for diabetes mellitus and type ii diabetes mellitus and has 28 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1712842","canonicalSmiles":"CC(=O)O.CN1CCCC(CN2c3ccccc3Sc3ccccc32)C1","inchiKey":"COBIOCPXKOZHSU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MEPAZINE ACETATE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL395110","hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"]},"tradeNames":[],"synonyms":["Mepazine acetate"],"crossReferences":{"PubChem":["49645132"]},"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in United States."}
{"id":"CHEMBL1725730","canonicalSmiles":"COc1ccc2c(c1)N(C[C@H](C)CN(C)C)c1ccccc1S2.O=C(O)/C=C\\C(=O)O","inchiKey":"IFLZPECPTYCEBR-VIEYUMQNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LEVOMEPROMAZINE MALEATE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL1764","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Levinan","Nozinan","Tisercin","Veractil"],"synonyms":["Levomepromazine maleate"],"crossReferences":{"PubChem":["144204110","93576617"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL1742995","drugType":"Antibody","blackBoxWarning":false,"name":"BRIAKINUMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Ozespa"],"synonyms":["A-796874.0","ABT-874","BSF 415977","BSF-415977","Briakinumab","J-695","J-695 BSF-415977 LU-415977 WAY-165772 A-796874.0","J695","LU 415977","LU-415977","WAY-165772"],"count":4,"linkedTargets":{"rows":["ENSG00000113302"],"count":1},"linkedDiseases":{"rows":["EFO_0003885","EFO_0000676","EFO_0000540","EFO_0000384"],"count":4},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL1743089","drugType":"Antibody","blackBoxWarning":false,"name":"VESENCUMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MNRP-1685A","MNRP1685A","RG-7347","Vesencumab"],"count":1,"linkedTargets":{"rows":["ENSG00000099250"],"count":1},"linkedDiseases":{"rows":["EFO_0000311"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1794734","canonicalSmiles":"C[C@@](O)(CCO)CC(=O)O","inchiKey":"KJTLQQUUPVSXIM-ZCFIWIBFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MEVALONIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mevalonic acid"],"crossReferences":{"drugbank":["DB03518"],"chEBI":["17710"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL187105","canonicalSmiles":"Oc1ccc2cc(-c3noc4cc(O)ccc34)ccc2c1","inchiKey":"LCGSYJVWLGYWTD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL187105","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07236"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL200469","canonicalSmiles":"CC(=O)c1ccc(NC(=O)c2cn[nH]c2-c2cc(Cl)c(O)cc2O)cc1","inchiKey":"BTTFXKUTBNGQTP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL200469","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06956"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2062262","canonicalSmiles":"C[C@H](N)[C@H](O)c1cccc(O)c1.O=C(O)C(O)C(O)C(=O)O","inchiKey":"VENXSELNXQXCNT-YDYUUSCQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METARAMINOL BITARTRATE","yearOfFirstApproval":1954,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201319","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aramine","Metaraminol bitartrate"],"synonyms":["Metaradrine bitartrate","Metaraminol bitartrate"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1954."}
{"id":"CHEMBL20835","canonicalSmiles":"CC(=O)OC1CN2CCC1CC2","inchiKey":"WRJPSSPFHGNBMG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ACECLIDINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Glaucostat"],"synonyms":["Aceclidine"],"crossReferences":{"PubChem":["26751840","507906"],"Wikipedia":["Aceclidine"],"drugbank":["DB13262"]},"childChemblIds":["CHEMBL4303558"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2104054","canonicalSmiles":"CC(=O)c1ccc2c(c1)N(CC(C)N(C)C)c1ccccc1S2","inchiKey":"XLOQNFNTQIRSOX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ACEPROMETAZINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Aceprometazine","CB 1664"],"crossReferences":{"drugbank":["DB01615"],"chEBI":["53770"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2104164","canonicalSmiles":"NC(=O)CN1Cc2ccccc2OC1=O","inchiKey":"KYCBWEZLKCTALM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CAROXAZONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Caroxazone","F.I. 6654"],"crossReferences":{"drugbank":["DB09254"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105681","canonicalSmiles":"CCCCCCCCCCCCCCCC(=O)Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2C#N)c(=O)n1","inchiKey":"LBGFKUUHOPIEMA-PEARBKPGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SAPACITABINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CS-682","CYC-682","CYC682","Sapacitabine"],"crossReferences":{"drugbank":["DB06365"]},"count":6,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL2105721","canonicalSmiles":"CC(C)[C@@]1(C(=O)N[C@H]2CC(=O)O[C@]2(O)CF)CC(c2nccc3ccccc23)=NO1","inchiKey":"VYFGDLGHHBUDTQ-ZLGUVYLKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NIVOCASAN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GS-9450","LB-84451","LB84451","Nivocasan"],"crossReferences":{"drugbank":["DB12720"]},"count":2,"linkedTargets":{"rows":["ENSG00000064012","ENSG00000132906","ENSG00000137752"],"count":3},"linkedDiseases":{"rows":["EFO_1001249","EFO_0003047"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2105738","canonicalSmiles":"C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@@]43C)[C@@H]1CC=C2n1cnc2ccccc21","inchiKey":"PAFKTGFSEFKSQG-PAASFTFBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GALETERONE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Galeterone","TOK 001","TOK-001","VN 124","VN-124","VN/124","VN/124-1"],"crossReferences":{"drugbank":["DB12415"]},"count":2,"linkedTargets":{"rows":["ENSG00000148795","ENSG00000169083"],"count":2},"linkedDiseases":{"rows":["EFO_0002618","MONDO_0008315"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2105752","canonicalSmiles":"CN(C)CCCOc1ccc2[nH]nc(S(=O)(=O)c3cccc4ccccc34)c2c1.Cl","inchiKey":"RNGAZJUESDPASQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CERLAPIRDINE HYDROCHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL2103880","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cerlapirdine hydrochloride","SAM-531"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2106627","canonicalSmiles":"CC(=O)Oc1ccc2c3c1O[C@H]1[C@@H](OC(C)=O)C=C[C@H]4[C@@H](C2)N(C)CC[C@]314.Cl","inchiKey":"FZJYQGFGNHGSFX-PVQKIFDLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIACETYLMORPHINE HYDROCHLORIDE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL459324","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Diacetylmorphine hydrochloride","Diacetylmorphine hydrochloride ci","Diamorphine","Diamorphine hydrochloride","Heroin hydrochloride","NSC-302357"],"crossReferences":{"PubChem":["144206407"]},"count":1,"approvedIndications":["EFO_0003890"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for drug dependence."}
{"id":"CHEMBL2107254","canonicalSmiles":"O=C1CN2CCOC2(c2ccccc2Cl)c2cc(Cl)ccc2N1","inchiKey":"ZIXNZOBDFKSQTC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLOXAZOLAM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cloxazolam"],"crossReferences":{"PubChem":["170465787"],"drugbank":["DB01553"],"chEBI":["31426"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2107371","canonicalSmiles":"CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NC4CCCC4)ncnc32)[C@H](O)[C@@H]1O","inchiKey":"GWVQGVCXFNYGFP-PFHKOEEOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SELODENOSON","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DTI-0009","GR-56072","GR56072","RG-14202","Selodenoson"],"count":1,"linkedTargets":{"rows":["ENSG00000163485"],"count":1},"linkedDiseases":{"rows":["EFO_0000275"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2107611","canonicalSmiles":"[Na+].[Na+].[S-2]","inchiKey":"GRVFOGOEDUUMBP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SODIUM SULFIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-41874","Sodium sulfide nonahydrate"],"crossReferences":{"drugbank":["DB11159"],"chEBI":["76208"]},"childChemblIds":["CHEMBL3989793"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2108129","drugType":"Enzyme","blackBoxWarning":false,"name":"SARUPLASE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Saruplase"],"count":1,"approvedIndications":["HP_0004419"],"description":"Enzyme drug with a maximum clinical trial phase of IV and is indicated for recurrent thrombophlebitis."}
{"id":"CHEMBL2108170","drugType":"Protein","blackBoxWarning":false,"name":"AVISCUMINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Aviscumine","CY-503","Cy-503","Mistletoe lectins aviscumine"],"count":1,"description":"Protein drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2108250","drugType":"Enzyme","blackBoxWarning":false,"name":"ANISTREPLASE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Eminase"],"synonyms":["APSAC","Anistreplase","BRL 26921"],"count":1,"approvedIndications":["HP_0004419"],"linkedTargets":{"rows":["ENSG00000122194"],"count":1},"linkedDiseases":{"rows":["HP_0004419"],"count":1},"description":"Enzyme drug with a maximum clinical trial phase of IV and is indicated for recurrent thrombophlebitis."}
{"id":"CHEMBL2108264","drugType":"Unknown","blackBoxWarning":false,"name":"CARRAGEENAN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Marine colloids"],"synonyms":["Carrageenan","E-407","INS NO.407","INS-407"],"count":2,"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2108348","drugType":"Protein","blackBoxWarning":false,"name":"NONACOG BETA PEGOL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Nonacog beta pegol"],"count":1,"description":"Protein drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2108357","drugType":"Antibody","blackBoxWarning":false,"name":"EPRATUZUMAB 90Y","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Lymphocide"],"synonyms":["AMG-412","Epratuzumab 90y","HLL2"],"count":1,"linkedTargets":{"rows":["ENSG00000012124"],"count":1},"linkedDiseases":{"rows":["EFO_0005952"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2108403","drugType":"Antibody","blackBoxWarning":false,"name":"EPITUMOMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Epitumomab"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2108894","drugType":"Unknown","blackBoxWarning":false,"name":"ALGINIC ACID","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Alginic acid","E-400","INS NO.400","INS-400"],"crossReferences":{"DrugCentral":["4321"]},"count":6,"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL2109268","drugType":"Antibody","blackBoxWarning":false,"name":"NARATUXIMAB EMTANSINE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DEBIO-1562","IMGN-529","IMGN529","Imgn529","Naratuximab emtansine"],"count":1,"linkedTargets":{"rows":["ENSG00000104894"],"count":1},"linkedDiseases":{"rows":["EFO_0000095"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2109310","drugType":"Antibody","blackBoxWarning":false,"name":"8H9 131I","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["8H9","8h9 131i"],"count":3,"linkedTargets":{"rows":["ENSG00000103855"],"count":1},"linkedDiseases":{"rows":["EFO_1001012","MONDO_0002087","EFO_0000621"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2109315","drugType":"Antibody","blackBoxWarning":false,"name":"MEDI-7184","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MEDI-7184"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2109445","drugType":"Antibody","blackBoxWarning":false,"name":"AD-439","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AD-439"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2110700","canonicalSmiles":"CC[N+](C)(CC)CCOC(=O)C(O)(c1cccs1)C1CCCC1","inchiKey":"NEMLPWNINZELKP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PENTHIENATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Penthienate"],"crossReferences":{"drugbank":["DB13695"]},"childChemblIds":["CHEMBL2105315"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2146126","canonicalSmiles":"[LiH]","inchiKey":"SIAPCJWMELPYOE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LITHIUM","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Lithium"],"crossReferences":{"chEBI":["30146"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2147777","canonicalSmiles":"Cc1cc(N2CCN([C@@H]3CN[C@H](C(=O)N4CCSC4)C3)CC2)n(-c2ccccc2)n1","inchiKey":"WGRQANOPCQRCME-PMACEKPBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TENELIGLIPTIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MP-513","Teneligliptin"],"crossReferences":{"drugbank":["DB11950"]},"childChemblIds":["CHEMBL2147708"],"count":2,"linkedTargets":{"rows":["ENSG00000197635"],"count":1},"linkedDiseases":{"rows":["EFO_0001360","EFO_0000400"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL215226","canonicalSmiles":"CN[C@@H]1[C@@H](O)[C@@H](O[C@@H]2[C@@H](O)[C@H](O[C@H]3O[C@H]([C@@H](C)O)[C@@H](O)[C@H](O)[C@H]3N)[C@@H](N)C[C@H]2N)OC[C@]1(C)O","inchiKey":"BRZYSWJRSDMWLG-DJWUNRQOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GENETICIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["G418"],"crossReferences":{"Wikipedia":["G418"],"drugbank":["DB04263"]},"childChemblIds":["CHEMBL2206186"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL221692","canonicalSmiles":"Fc1ccc(-c2cncc(CN3CCN(c4cccc5c4OCCO5)CC3)c2)cc1","inchiKey":"IUVSEUFHPNITEQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ADOPRAZINE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Adoprazine","SLV-313"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL222501","canonicalSmiles":"C=CCn1nc(-c2ccc(O)cc2O)c2cccc(C(F)(F)F)c21","inchiKey":"ZDUDMCQPFKPISO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"WAY-169916","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["WAY-169916"],"crossReferences":{"drugbank":["DB08047"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2386346","canonicalSmiles":"CCOc1cc(C(C)(C)C)ccc1C1=N[C@@](C)(c2ccc(Cl)cc2)[C@@](C)(c2ccc(Cl)cc2)N1C(=O)N1CCN(CCCS(C)(=O)=O)CC1","inchiKey":"QBGKPEROWUKSBK-QPPIDDCLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RO-5045337","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["R 7112","RG-7112","RG7112","RO-5045337","RO5045337","Ro-5045337"],"crossReferences":{"drugbank":["DB14793"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2424780","canonicalSmiles":"CCCCOc1nc(N)c2c(n1)N(Cc1cccc(CN3CCCC3)c1)CC(=O)N2","inchiKey":"VFOKSTCIRGDTBR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VESATOLIMOD","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GS-9620","Vesatolimod"],"crossReferences":{"drugbank":["DB12687"]},"count":5,"linkedTargets":{"rows":["ENSG00000196664"],"count":1},"linkedDiseases":{"rows":["EFO_0000765","EFO_0000180","EFO_0004197","EFO_0003047","EFO_0004239"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL2447938","canonicalSmiles":"O=[O+][O-]","inchiKey":"CBENFWSGALASAD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OZONE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ozone"],"crossReferences":{"drugbank":["DB12510"],"chEBI":["25812"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL255476","canonicalSmiles":"CCCC(=O)N[C@H]1/C(=N/OC(=O)Nc2ccccc2)O[C@H](CO)[C@@H](O)[C@@H]1O","inchiKey":"ITVRELFVFCOUMV-ZVZWZHPPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL255476","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07432"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL257975","canonicalSmiles":"O=P(O)(O)OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O","inchiKey":"NBSCHQHZLSJFNQ-VFUOTHLCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Glucose-6-Phosphate","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Glucose-6-Phosphate"],"crossReferences":{"drugbank":["DB04122"],"chEBI":["17719"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL259548","canonicalSmiles":"C[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@H]2CC[C@@]3(C)[C@@H](CC[C@]3(C)O)[C@@H]21","inchiKey":"IVFYLRMMHVYGJH-VLOLGRDOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BOLASTERONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bolasterone","U-19763"],"crossReferences":{"drugbank":["DB01471"],"chEBI":["34583"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL266481","canonicalSmiles":"CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1c[nH]cn1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)O)[C@@H](C)O","inchiKey":"MASNOZXLGMXCHN-ZLPAWPGGSA-N","drugType":"Protein","blackBoxWarning":false,"name":"GLUCAGON","yearOfFirstApproval":1998,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Baqsimi","Glucagen Hypokit","Glucagon","Glucagon Emergency Kit","Gvoke hypopen","Gvoke pfs"],"synonyms":["Glucagon","Glucagon recombinant"],"crossReferences":{"DailyMed":["glucagon"],"PubChem":["50112436"],"Wikipedia":["Glucagon"],"chEBI":["5391"]},"count":8,"linkedTargets":{"rows":["ENSG00000215644"],"count":1},"linkedDiseases":{"rows":["EFO_0000545","EFO_0001359","Orphanet_657","HP_0001943","EFO_0001360","EFO_0000400","EFO_0001073","EFO_0007214","EFO_0007318"],"count":9},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1998 and has 8 investigational indications."}
{"id":"CHEMBL270686","canonicalSmiles":"COc1ccnc2[nH]cc(-c3ccnc(N)n3)c12","inchiKey":"GGEWEQJWGGJUHO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MERIOLIN 3","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08178"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL279516","canonicalSmiles":"O=C(NC1CCN(CCc2c[nH]c3ccccc23)CC1)c1ccccc1","inchiKey":"JXZZEXZZKAWDSP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"INDORAMIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Baratol","Doralese tiltab"],"synonyms":["Indoramin","WY 21901"],"crossReferences":{"PubChem":["29217568","49671666"],"Wikipedia":["Indoramin"],"drugbank":["DB08950"]},"childChemblIds":["CHEMBL2104941"],"count":1,"approvedIndications":["EFO_0000537"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for hypertension."}
{"id":"CHEMBL285802","canonicalSmiles":"CN(C)CCOC1=Cc2ccccc2Sc2ccc(Cl)cc21","inchiKey":"HDOZVRUNCMBHFH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ZOTEPINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Zoleptil 100","Zoleptil 25","Zoleptil 50"],"synonyms":["Zotepine"],"crossReferences":{"PubChem":["144206686","170465934"],"Wikipedia":["Zotepine"],"drugbank":["DB09225"],"chEBI":["32316"]},"count":1,"approvedIndications":["EFO_0005407"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for psychosis."}
{"id":"CHEMBL292707","canonicalSmiles":"CC(C)Cc1ccc(C(C)C(=O)NO)cc1","inchiKey":"BYPIURIATSUHDW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IBUPROXAM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ibuproxam"],"crossReferences":{"drugbank":["DB08955"],"chEBI":["76160"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL297273","canonicalSmiles":"Nc1nc(O)c2nn(-c3cccc(C(=O)NCc4ccccc4Sc4ccccc4CO)c3)nc2n1","inchiKey":"IXDQOBDHBWEZOH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL297273","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03231"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3039502","canonicalSmiles":"C[C@H](Nc1ncnc2nc[nH]c12)c1cc2cccc(Cl)c2c(=O)n1-c1ccccc1","inchiKey":"SJVQHLPISAIATJ-ZDUSSCGKSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"DUVELISIB","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Copiktra"],"synonyms":["Duvelisib","INK-1147","INK-1197","IPI-145"],"crossReferences":{"DailyMed":["duvelisib"],"drugbank":["DB11952"]},"count":13,"approvedIndications":["EFO_0000096","EFO_0000095","MONDO_0018906"],"linkedTargets":{"rows":["ENSG00000171608","ENSG00000105851"],"count":2},"linkedDiseases":{"rows":["EFO_0000685","EFO_0005952","MONDO_0044881","EFO_0000311","EFO_0000565","EFO_0000211","MONDO_0100096","EFO_0000096","EFO_0000095","EFO_0000270","EFO_0001421","EFO_0000574","MONDO_0018906","MONDO_0002083","EFO_0000181"],"count":15},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2018 and has 3 approved and 10 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL3039526","canonicalSmiles":"CN1CCC(C(=O)c2cccc(NC(=O)c3c(F)cc(F)cc3F)n2)CC1.CN1CCC(C(=O)c2cccc(NC(=O)c3c(F)cc(F)cc3F)n2)CC1.O=C(O)CCC(=O)O","inchiKey":"MSOIHUHNGPOCTH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LASMIDITAN SUCCINATE","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL3039520","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Reyvow"],"synonyms":["LY683974","Lasmiditan succinate"],"crossReferences":{"DailyMed":["lasmiditan%20succinate"]},"count":1,"approvedIndications":["EFO_0003821"],"linkedTargets":{"rows":["ENSG00000179097"],"count":1},"linkedDiseases":{"rows":["EFO_0003821"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2020 and is indicated for migraine disorder."}
{"id":"CHEMBL3109278","canonicalSmiles":"CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\\C(=O)Nc3ccc(F)cc32)c1C.O=C(O)CC(O)C(=O)O","inchiKey":"LBWFXVZLPYTWQI-HBPAQXCTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3109278","maximumClinicalTrialPhase":0,"parentId":"CHEMBL535","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["160651837"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3137323","canonicalSmiles":"Cl.O=C(N[C@H]1CN2CCC1CC2)c1cc2cccc(Cl)c2s1","inchiKey":"OIJYTJGIDVTCFF-ZOWNYOTGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ENCENICLINE HYDROCHLORIDE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL2151572","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["EVP-6124","EVP-6124 HYDROCHLORIDE","Encenicline hydrochloride"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3137350","drugType":"Antibody","blackBoxWarning":false,"name":"DIRIDAVUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CR-6261","CR6261","Diridavumab"],"count":2,"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3183376","canonicalSmiles":"CNC[C@H](O)c1ccc(O)c(O)c1.Cl","inchiKey":"ATADHKWKHYVBTJ-FVGYRXGTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EPINEPHRINE HYDROCHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL679","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["170464974"],"chEBI":["6213"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3185360","canonicalSmiles":"CC(C)OC(=O)OCOP(=O)(CO[C@H](C)Cn1cnc2c(N)ncnc21)OCOC(=O)OC(C)C.O=C(O)C=CC(=O)O","inchiKey":"VCMJCVGFSROFHV-PFEQFJNWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3185360","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1538","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["170465338"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3185463","canonicalSmiles":"CN1CCN(c2ccccc2/C=C2\\SCCN(c3ccc(Cl)c(Cl)c3)C2=O)CC1","inchiKey":"LHYMPSWMHXUWSK-STZFKDTASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ELZASONAN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Elzasonan"],"crossReferences":{"PubChem":["144210759"]},"childChemblIds":["CHEMBL3989903","CHEMBL3989805"],"count":1,"linkedTargets":{"rows":["ENSG00000135312","ENSG00000179546"],"count":2},"linkedDiseases":{"rows":["MONDO_0002009"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL321130","canonicalSmiles":"N[C@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)NCc1cccc(Cl)c1","inchiKey":"CJHLRGCXPGIPCB-MOPGFXCFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL321130","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06919"]},"childChemblIds":["CHEMBL599035"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3286580","canonicalSmiles":"Fc1ccc2c(CCNCc3cccc(OCC(F)(F)C(F)F)c3)c[nH]c2c1","inchiKey":"YBAWYTYNMZWMMJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IDALOPIRDINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Idalopirdine","LU AE-58054","LU-AE-58054","LU-AE58054","LY-483518","LY483518","Lu AE58054","Lu-ae58054","SGS-518","SGS518"],"crossReferences":{"drugbank":["DB11957"]},"count":2,"linkedTargets":{"rows":["ENSG00000158748"],"count":1},"linkedDiseases":{"rows":["EFO_0000249","EFO_0000692"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3301581","drugType":"Protein","blackBoxWarning":true,"name":"ABALOPARATIDE","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Tymlos"],"synonyms":["Abaloparatide","BA-058","BA058","BIM-44058"],"crossReferences":{"DailyMed":["abaloparatide"]},"count":2,"approvedIndications":["EFO_0003882"],"linkedTargets":{"rows":["ENSG00000160801"],"count":1},"linkedDiseases":{"rows":["EFO_0003931","EFO_0003854","EFO_0003882"],"count":3},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2017 and is indicated for osteoporosis and has 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL3544910","drugType":"Small molecule","blackBoxWarning":false,"name":"MOTEXAFIN GADOLINIUM","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Xcytrin"],"synonyms":["API-GP3","FP-GP1","GD-TEXAPHYRIN","Gd texaphyrin","Gd-Tex","Motexafin gadolinium","NSC-695238","PCI-0120","gadolinium texaphyrin"],"crossReferences":{"chEBI":["50161"]},"count":17,"linkedTargets":{"rows":["ENSG00000048392","ENSG00000167325","ENSG00000198431","ENSG00000171848"],"count":4},"linkedDiseases":{"rows":["EFO_0002618","MONDO_0021321","EFO_0000681","EFO_1001465","EFO_0005952","EFO_0000228","EFO_0003060","EFO_0000632","EFO_0009708","EFO_0003863","EFO_0000095","MONDO_0008903","MONDO_0005411","MONDO_0002367","EFO_0001378","MONDO_0003869","MONDO_0024880","EFO_0003833","EFO_0000519","EFO_1000158"],"count":20},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 17 investigational indications."}
{"id":"CHEMBL3545070","drugType":"Enzyme","blackBoxWarning":false,"name":"VONAPANITASE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PRT-201","PRT201","Vonapanitase"],"count":2,"linkedTargets":{"rows":["ENSG00000049540"],"count":1},"linkedDiseases":{"rows":["EFO_0003884","EFO_0004265"],"count":2},"description":"Enzyme drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3545072","drugType":"Antibody","blackBoxWarning":false,"name":"LANDOGROZUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LY-2495655","LY2495655","Landogrozumab"],"count":3,"linkedTargets":{"rows":["ENSG00000138379"],"count":1},"linkedDiseases":{"rows":["EFO_0002618","EFO_0002970","EFO_0000311"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3545077","drugType":"Small molecule","blackBoxWarning":false,"name":"MK-1496","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mk-1496"],"count":1,"linkedTargets":{"rows":["ENSG00000166851"],"count":1},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3545180","drugType":"Small molecule","blackBoxWarning":false,"name":"THELIATINIB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["HMPL-309","Hmpl-309","Theliatinib","Xiliertinib"],"count":1,"linkedTargets":{"rows":["ENSG00000146648"],"count":1},"linkedDiseases":{"rows":["EFO_0000311"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3545270","drugType":"Small molecule","blackBoxWarning":false,"name":"LY2969822","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ly2969822"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3590106","canonicalSmiles":"CC(C)Nc1cc(-c2c[nH]c(C(=O)N[C@H](CO)c3cccc(Cl)c3)c2)c(Cl)cn1","inchiKey":"KSERXGMCDHOLSS-LJQANCHMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3590106","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB13930"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL36506","canonicalSmiles":"CO[C@@H]1[C@@H](OC(N)=O)[C@@H](O)[C@H](Oc2ccc3c(O)c(NC(=O)c4ccc(O)c(CC=C(C)C)c4)c(=O)oc3c2C)OC1(C)C","inchiKey":"YJQPYGGHQPGBLI-KGSXXDOSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NOVOBIOCIN","yearOfFirstApproval":1964,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"],"classes":["Dermatological toxicity"," Hematological toxicity"," Hepatotoxicity"],"year":2009},"tradeNames":["Albamycin t"],"synonyms":["Albamycin","Cathomycin","Novobiocin"],"crossReferences":{"PubChem":["26755282"],"Wikipedia":["Novobiocin"],"drugbank":["DB01051"],"chEBI":["28368"]},"childChemblIds":["CHEMBL3544972","CHEMBL3183453"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1964 and has 1 investigational indication. It was withdrawn in United States  in 2009 due to Dermatological toxicity,  Hematological toxicity and  Hepatotoxicity."}
{"id":"CHEMBL3707328","drugType":"Antibody","blackBoxWarning":false,"name":"GALCANEZUMAB","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Emgality"],"synonyms":["Galcanezumab","Galcanezumab-gnlm","LY-2951742","LY2951742"],"crossReferences":{"DailyMed":["galcanezumab-gnlm"]},"count":3,"approvedIndications":["EFO_0003821"],"linkedTargets":{"rows":["ENSG00000110680","ENSG00000175868"],"count":2},"linkedDiseases":{"rows":["EFO_1001219","EFO_0003821","EFO_0004616","EFO_0003843"],"count":4},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2018 and is indicated for migraine disorder and has 2 investigational indications."}
{"id":"CHEMBL372764","canonicalSmiles":"CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](C)(C)CC1","inchiKey":"SZFPYBIJACMNJV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PERIFOSINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["KRX-0401","NSC-639966","Perifosine"],"crossReferences":{"PubChem":["144206916","225144339","499931"],"Wikipedia":["Perifosine"],"drugbank":["DB06641"],"chEBI":["67272"]},"count":37,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 37 investigational indications."}
{"id":"CHEMBL3828074","canonicalSmiles":"CCc1nc2c(C)cc(N3CCN(CC(=O)N4CC(O)C4)CC3)cn2c1N(C)c1nc(-c2ccc(F)cc2)c(C#N)s1","inchiKey":"REQQVBGILUTQNN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ZIRITAXESTAT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["G451990","GLPG1690","Glpg1690","Ziritaxestat","Ziritaxestatn"],"crossReferences":{"drugbank":["DB15403"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3900409","canonicalSmiles":"Cn1c(=O)oc2ccc(-c3ccc(C[C@@H](C#N)NC(=O)[C@@H]4CNCCCO4)cc3)cc21","inchiKey":"AEXFXNFMSAAELR-RXVVDRJESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZD-7986","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZD 7986","AZD-7986","AZD7986","Azd-7986","Azd7986","Brensocatib","INS-1007","INS1007"],"crossReferences":{"drugbank":["DB15638"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL395110","canonicalSmiles":"CN1CCCC(CN2c3ccccc3Sc3ccccc32)C1","inchiKey":"CBHCDHNUZWWAPP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MEPAZINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"]},"tradeNames":[],"synonyms":["Pecazine"],"crossReferences":{"PubChem":["144205395","29216162"]},"childChemblIds":["CHEMBL1712842"],"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in United States."}
{"id":"CHEMBL3989559","canonicalSmiles":"COc1ccnc(C[S+]([O-])c2nc3cc(OC(F)F)ccc3[n-]2)c1OC.O.[Na+]","inchiKey":"CGJRLPRCWSHOFU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PANTOPRAZOLE SODIUM","yearOfFirstApproval":2000,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1502","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Pantoprazole sodium","Protonix","Protonix iv"],"synonyms":["Pantoprazole sodium","Pantoprazole sodium hydrate","Pantoprazole sodium sesquihydrate"],"crossReferences":{"DailyMed":["pantoprazole%20sodium"]},"count":5,"approvedIndications":["EFO_0003948","EFO_0007549","HP_0100633"],"linkedTargets":{"rows":["ENSG00000105675"],"count":1},"linkedDiseases":{"rows":["EFO_0003948","EFO_0000616","Orphanet_79292","EFO_0007549","HP_0100633"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2000 and has 3 approved and 2 investigational indications."}
{"id":"CHEMBL3989983","drugType":"Antibody","blackBoxWarning":false,"name":"COFETUZUMAB PELIDOTIN","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cofetuzumab pelidotin","PF-06647020"],"count":1,"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3990022","drugType":"Antibody","blackBoxWarning":false,"name":"VONLEROLIZUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MOXR-0916","MOXR0916","Pogalizumab","R0-7021608","R07021608","RO7021608","Vonlerolizumab"],"count":2,"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL407009","canonicalSmiles":"NC(=O)C1=CN([C@@H]2O[C@H](COP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n4cnc5c(N)ncnc54)[C@H](OP(=O)(O)O)[C@@H]3O)[C@@H](O)[C@H]2O)C=CC1","inchiKey":"ACFIXJIJDZMPPO-NNYOXOHSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL407009","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02338"],"chEBI":["16474"]},"childChemblIds":["CHEMBL1256015"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL426559","canonicalSmiles":"CS(=O)(=O)c1cc(F)cc2c3c(n(Cc4ccc(Cl)cc4)c12)[C@@H](CC(=O)O)CC3","inchiKey":"NXFFJDQHYLNEJK-CYBMUJFWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LAROPIPRANT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Laropiprant","MK-0524"],"crossReferences":{"Wikipedia":["Laropiprant"],"drugbank":["DB11629"]},"childChemblIds":["CHEMBL218415","CHEMBL375527"],"count":8,"linkedTargets":{"rows":["ENSG00000168229"],"count":1},"linkedDiseases":{"rows":["EFO_1000760","HP_0003124","EFO_0001645","Orphanet_79211","EFO_0003774","EFO_0001360","EFO_0000660","HP_0031284","Orphanet_309005","EFO_0004911"],"count":10},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL4297270","canonicalSmiles":"Cc1noc(-c2ccc(-c3ccc(C4(C(=O)O)CC4)cc3)cc2)c1NC(=O)O[C@H](C)c1ccccc1","inchiKey":"GQBRZBHEPUQRPL-LJQANCHMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BMS-986020","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AP-3152 FREE ACID","Bms-986020"],"crossReferences":{"drugbank":["DB14948"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297386","canonicalSmiles":"COCCOc1cc(Cn2c(C(=O)O)c(-c3ccc(C(C)(C)C)cc3)c3ccccc32)cc(OCCOC)c1","inchiKey":"OIDYMQICWGYEDR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GSK-376501","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GSK-376501A","GSK376501","GSK376501A","Gsk-376501","Gsk376501"],"crossReferences":{"drugbank":["DB12654"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297412","canonicalSmiles":"CC1(C)C(/C=C/C2=C(Oc3ccc(C[C@H](NC(=O)c4ccc(NCc5cnc6nc(N)[nH]c(=O)c6n5)cc4)C(=O)O)cc3)/C(=C/C=C3/N(CCCCS(=O)(=O)O)c4ccc(S(=O)(=O)O)cc4C3(C)C)CCC2)=[N+](CCCCS(=O)(=O)O)c2ccc(S(=O)(=O)[O-])cc21","inchiKey":"PDXNSXLPXJFETD-DYVQZXGMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PAFOLACIANINE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["OTL 0038","OTL 38","OTL-0038","OTL-38","OTL0038","OTL38","Otl-38","Otl0038","Pafolacianine"],"crossReferences":{"drugbank":["DB15413"]},"childChemblIds":["CHEMBL4594383"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297459","canonicalSmiles":"O=C1CCC(N2C(=O)c3cccc(CNC(=O)C4CC4)c3C2=O)C(=O)N1","inchiKey":"ZBXHNCURDISBRO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CC-11006","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CC 11006","CC-11006","Cc-11006"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297605","canonicalSmiles":"O=C(CN1CCC(CN2Cc3ccccc3C2=O)CC1)c1ccc(F)cc1","inchiKey":"RNRYULFRLCBRQS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ROLUPERIDONE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["FMI","MIN-101 FREE BASE","Roluperidone"],"crossReferences":{"drugbank":["DB13080"]},"childChemblIds":["CHEMBL4298043"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4297689","drugType":"Unknown","blackBoxWarning":false,"name":"ALT-801","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Alt-801"],"count":5,"description":"Unknown drug with a maximum clinical trial phase of I (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL4297721","drugType":"Unknown","blackBoxWarning":false,"name":"CDX-1140","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CDX-1140","Cdx-1140"],"count":14,"description":"Unknown drug with a maximum clinical trial phase of I (across all indications) and has 14 investigational indications."}
{"id":"CHEMBL4297738","drugType":"Protein","blackBoxWarning":false,"name":"DALAZATIDE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dalazatide","SHK-186"],"count":1,"description":"Protein drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297754","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"FITUSIRAN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ALN-57213","ALN-AT3SC","Aln-at3sc","Fitusiran"],"count":3,"description":"Oligonucleotide drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297770","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"INOTERSEN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["GSK-2998728","ISIS 420915","ISIS-420915","Inotersen"],"count":2,"linkedTargets":{"rows":["ENSG00000118271"],"count":1},"linkedDiseases":{"rows":["EFO_1001875","Orphanet_85447"],"count":2},"description":"Oligonucleotide drug with a maximum clinical trial phase of IV (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297777","drugType":"Unknown","blackBoxWarning":false,"name":"LMB-100","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LMB-100","Lmb 100","Lmb-100","RG-7787","RG7787","RO-6927005","RO6927005","Ro6927005"],"count":4,"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL4297903","drugType":"Protein","blackBoxWarning":false,"name":"PEPTIDE B27PD","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["B-27PD","B27PD","B27pd","Peptide b27pd"],"count":1,"description":"Protein drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297939","drugType":"Unknown","blackBoxWarning":false,"name":"DS-1062","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ADC DS-1062A","DS-1062","DS-1062A","DS1062","Datopotamab deruxtecan","Ds-1062","Ds-1062a"],"count":2,"description":"Unknown drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4298023","drugType":"Unknown","blackBoxWarning":false,"name":"M-1095","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ALX-0761","ALX0761","M-1095","M1095","Sonelokimab"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4298100","drugType":"Unknown","blackBoxWarning":false,"name":"SAR-441236","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SAR-441236","SAR441236","Sar 441236","Sar-441236","Sar441236"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4298178","drugType":"Antibody","blackBoxWarning":false,"name":"TRASTUZUMAB DUOCARMAZINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SYD-985","SYD985","Trastuzumab duocarmazine"],"count":3,"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4298192","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"SUVODIRSEN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMTR0139","Suvodirsen","WLS-4176","WV-3473","WVE-210201","Wve-210201"],"count":1,"description":"Oligonucleotide drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4298209","drugType":"Antibody","blackBoxWarning":true,"name":"BELANTAMAB MAFODOTIN","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Blenrep"],"synonyms":["Belantamab mafodotin","Belantamab mafodotin-blmf","GSK-2857916","GSK2857916"],"crossReferences":{"DailyMed":["belantamab%20mafodotin-blmf"]},"count":1,"approvedIndications":["EFO_0001378"],"linkedTargets":{"rows":["ENSG00000261456","ENSG00000188229","ENSG00000104833","ENSG00000137267","ENSG00000258947","ENSG00000101162","ENSG00000048462","ENSG00000137285","ENSG00000196230","ENSG00000176014"],"count":10},"linkedDiseases":{"rows":["EFO_0001378","Orphanet_85443"],"count":2},"description":"Antibody drug with a maximum clinical trial phase of IV that was first approved in 2020 and is indicated for multiple myeloma. This drug has a black box warning from the FDA."}
{"id":"CHEMBL444963","canonicalSmiles":"CCC(=O)O[C@H]1[C@H](C)O[C@@H](O[C@@H]2[C@@H](C)O[C@@H](O[C@@H]3[C@@H](OC)[C@H](OC(=O)CC)CC(=O)O[C@H](C)C/C=C/C=C/[C@H](O)[C@H](C)C[C@@H]3CC=O)[C@H](O)[C@H]2N(C)C)C[C@@]1(C)O","inchiKey":"DMUAPQTXSSNEDD-QALJCMCCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL444963","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144204186"],"drugbank":["DB13456"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL459265","canonicalSmiles":"CN(C)c1ccc(C(=C2C=CC(=[N+](C)C)C=C2)c2ccc(N(C)C)cc2)cc1","inchiKey":"LGLFFNDHMLKUMI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HEXAMETHYL PARAROSANILINE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["124890459"],"drugbank":["DB00406"],"chEBI":["77181"]},"childChemblIds":["CHEMBL64894"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL4594292","canonicalSmiles":"CN1CCC(COc2cnc(-c3cccc(Cn4nc(-c5cccc(C#N)c5)ccc4=O)c3)nc2)CC1.Cl.O","inchiKey":"KZVOMLRKFJUTLK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TEPOTINIB HYDROCHLORIDE","maximumClinicalTrialPhase":1,"parentId":"CHEMBL3402762","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MSC2156119J","Msc2156119j","Tepotinib hydrochloride"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4594596","drugType":"Unknown","blackBoxWarning":false,"name":"REGN-4659","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["REGN-4659","REGN4659","Regn-4659","Regn4659"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL461332","canonicalSmiles":"CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(Cl)[C@@H](Cl)C[C@]3(C)[C@]2(C(=O)CO)O1","inchiKey":"NJNWEGFJCGYWQT-VSXGLTOVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLUCLORONIDE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Topilar"],"synonyms":["Fluclorolone acetonide","Flucloronide","RS-2252"],"crossReferences":{"drugbank":["DB08973"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL461343","canonicalSmiles":"N/C(=N\\O)N/N=C/c1c(Cl)cccc1Cl","inchiKey":"QKIQJNNDIWGVEH-UUILKARUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GUANOXABENZ","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["43-663","Guanoxabenz"],"crossReferences":{"Wikipedia":["Guanoxabenz"],"drugbank":["DB13410"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL469099","canonicalSmiles":"CC1(C)CC(=O)c2sc(N3CCOCC3)nc2C1","inchiKey":"DZXMARZBAUMWLK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL469099","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07073"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL47259","canonicalSmiles":"CCCCCl","inchiKey":"VFWCMGCRMGJXDK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BUTYL CHLORIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Butyl chloride"],"crossReferences":{"PubChem":["144204623","144208063","17390003"],"Wikipedia":["1-Chlorobutane"],"drugbank":["DB11534"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL48582","canonicalSmiles":"CS(=O)(=O)O.C[C@H](NCc1ccc(OCc2cccc(F)c2)cc1)C(N)=O","inchiKey":"YKOCHIUQOBQIAC-YDALLXLXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SAFINAMIDE MESYLATE","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL396778","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Xadago"],"synonyms":["EMD 1195686","PNU-151774E","Safinamide mesylate"],"crossReferences":{"DailyMed":["safinamide%20mesylate"]},"count":1,"approvedIndications":["EFO_0002508"],"linkedTargets":{"rows":["ENSG00000069535"],"count":1},"linkedDiseases":{"rows":["EFO_0002508"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2017 and is indicated for parkinson's disease."}
{"id":"CHEMBL487894","canonicalSmiles":"Cc1c(N(C)CS(=O)(=O)[O-])c(=O)n(-c2ccccc2)n1C.[Na+]","inchiKey":"DJGAAPFSPWAYTJ-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"DIPYRONE SODIUM","maximumClinicalTrialPhase":0,"parentId":"CHEMBL461522","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["11112965","144204310","144207695","170465672","26748775","57264368"],"Wikipedia":["Metamizole"],"chEBI":["59033"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL488436","canonicalSmiles":"Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C","inchiKey":"WJRRGYBTGDJBFX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZD-5438","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZD-5438","Azd-5438"],"childChemblIds":["CHEMBL454649"],"count":1,"linkedTargets":{"rows":["ENSG00000250506","ENSG00000156345","ENSG00000164885","ENSG00000134058","ENSG00000123374","ENSG00000135446","ENSG00000155111","ENSG00000059758","ENSG00000167258","ENSG00000105810","ENSG00000136807","ENSG00000138395","ENSG00000058091","ENSG00000248333","ENSG00000117266","ENSG00000132964","ENSG00000065883","ENSG00000102225","ENSG00000170312","ENSG00000185324"],"count":20},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL494089","canonicalSmiles":"CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21","inchiKey":"KGPGFQWBCSZGEL-ZDUSSCGKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GSK-690693","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GSK 690693","GSK690693","Gsk-690693"],"crossReferences":{"drugbank":["DB12745"],"chEBI":["90677"]},"count":1,"linkedTargets":{"rows":["ENSG00000154229","ENSG00000142875","ENSG00000165059","ENSG00000065675","ENSG00000126583","ENSG00000171132","ENSG00000166501","ENSG00000105221","ENSG00000117020","ENSG00000163558","ENSG00000115825","ENSG00000067606","ENSG00000163932","ENSG00000027075","ENSG00000072062","ENSG00000142208","ENSG00000184304"],"count":17},"linkedDiseases":{"rows":["EFO_0000311"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL497058","canonicalSmiles":"Cc1ccc(NC(=O)NCCSCc2ccc(CN(C)C)o2)cc1Cl","inchiKey":"WEYNBWVKOYCCQT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL497058","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08027"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL501822","canonicalSmiles":"O=C(O)Cc1ccc(O)c([N+](=O)[O-])c1","inchiKey":"QBHBHOSRLDPIHG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL501822","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08294"],"chEBI":["546274"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL521589","canonicalSmiles":"CN(C)C(=O)Oc1cc(OC(=O)N(C)C)cc(C(O)CNC(C)(C)C)c1","inchiKey":"ANZXOIAKUNOVQU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BAMBUTEROL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bambuterol"],"crossReferences":{"PubChem":["56463628"],"Wikipedia":["Bambuterol"],"drugbank":["DB01408"],"chEBI":["553827"]},"childChemblIds":["CHEMBL1603534"],"count":2,"linkedTargets":{"rows":["ENSG00000169252"],"count":1},"linkedDiseases":{"rows":["HP_0006536","EFO_0001361","EFO_0000270","EFO_0009661","EFO_0000341"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL526330","canonicalSmiles":"O[C@H]1[C@H]2CC[C@](O)(N2)[C@@H](O)[C@@H]1O","inchiKey":"FXFBVZOJVHCEDO-IBISWUOJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CALYSTEGINE B2","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04658"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL542103","canonicalSmiles":"CC(C)c1cccc(C(C)C)c1NC(=O)NCC1(c2ccc(N(C)C)cc2)CCCC1.Cl","inchiKey":"SDOOGTHIDFZUNM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NEVANIMIBE HYDROCHLORIDE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL46423","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ATR-101","ATR-101 HYDROCHLORIDE","Atr-101","Nevanimibe hydrochloride","PD 132301-02","PD-132301 HYDROCHLORIDE","PD-132301-02","PD-132301-2","PD132301-02","PD132301-2"],"count":3,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL545","canonicalSmiles":"CCO","inchiKey":"LFQSCWFLJHTTHZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALCOHOL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ablysinol","Ethanol","Ethyl Alcohol","Methylated mineral","Spirigel","Surg"],"synonyms":["Alcohol","Alcohol determination--alcohol","Alcohol, Diluted","Alcohol, Rubbing","Alcohol, diluted","Alcohol, rubbing","Anhydrous ethanol","B3324","E1510","Ethanol","Ethyl alcohol","FEMA NO. 2419","NCI-C03134","NSC-85228","PM-6193-200","Vodka"],"crossReferences":{"PubChem":["144209708","17389892"],"TG-GATEs":["137"],"Wikipedia":["Ethanol"],"drugbank":["DB00898"],"chEBI":["16236"]},"count":35,"approvedIndications":["EFO_0003843"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for pain and has 34 investigational indications."}
{"id":"CHEMBL560","canonicalSmiles":"CC(C)=CCN1CC[C@@]2(C)c3cc(O)ccc3C[C@@H]1[C@@H]2C","inchiKey":"VOKSWYLNZZRQPF-GDIGMMSISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PENTAZOCINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pentazocine"],"crossReferences":{"Wikipedia":["Pentazocine"],"drugbank":["DB00652"],"chEBI":["7982"]},"childChemblIds":["CHEMBL1200327","CHEMBL2360021"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL572964","canonicalSmiles":"O=S(=O)(O)O","inchiKey":"QAOWNCQODCNURD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SULFURIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["E513","Sulfuric acid"],"crossReferences":{"PubChem":["144207681"],"Wikipedia":["Sulfuric_acid"],"drugbank":["DB11309"],"chEBI":["26836"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL573","canonicalSmiles":"O=C(O)c1cccnc1","inchiKey":"PVNIIMVLHYAWGP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NIACIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Niacin","Niacin Td","Niacor","Niaspan","Niaspan Er","Niaspan titration starter pack","Nicangin","Nicolar","Simcor","Wampocap"],"synonyms":["NSC-169454","Niacin","Nicotinate","Nicotinic acid"],"crossReferences":{"DailyMed":["niacin"],"PubChem":["104171277","11112153","144203888","144208618","144213221","170465044","174007257","8139875"],"TG-GATEs":["81"],"Wikipedia":["Niacin"],"drugbank":["DB00627"],"chEBI":["15940"]},"count":34,"approvedIndications":["HP_0003124","EFO_0003884","EFO_0004272","EFO_0003774","EFO_0003894","HP_0001891"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 6 approved and 28 investigational indications."}
{"id":"CHEMBL590284","canonicalSmiles":"COc1ccc2c(c1)c(CC(=O)O)c(C)n2C(=O)c1ccc(I)cc1","inchiKey":"CXBFZYKAVCAPSV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IODOINDOMETHACIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Iodoindomethacin"],"crossReferences":{"drugbank":["DB07983"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL632","canonicalSmiles":"C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO","inchiKey":"UREBDLICKHMUKA-DVTGEIKXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BETAMETHASONE","yearOfFirstApproval":1961,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Alphatrex","Betasolan","Betatrex","Betnelan","Celestone","Dermabet","Uticort"],"synonyms":["BETA-VAL","Betamethasone","Betatrex","Dermabet","Flubenisolone","Lotrisone","NSC-39470","SCH 4831","SCH-4831","Taclonex","Uticort","VISUBETA"],"crossReferences":{"PubChem":["144205668","144211772","170465027","26757820","46500420","56320847"],"Wikipedia":["Betamethasone"],"drugbank":["DB00443"],"chEBI":["3077"]},"count":28,"approvedIndications":["HP_0006536","EFO_0009552","HP_0001742","EFO_0005752"],"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["MONDO_0003005","EFO_0010822","EFO_1001034","EFO_1001494","EFO_1001104","HP_0012735","EFO_0000756","EFO_1001435","MONDO_0002959","EFO_1000644","EFO_0000274","EFO_1000637","EFO_0009840","HP_0004798","HP_0011868","HP_0011950","EFO_0002950","EFO_0002506","EFO_0000676","EFO_0004143","EFO_0009552","EFO_0003917","EFO_0008517","EFO_0009321","EFO_0005752","EFO_0005854","EFO_0009686","EFO_0000685","EFO_0008521","HP_0012532","EFO_0003821","HP_0000964","EFO_0000232","EFO_1001157","HP_0001742","HP_0006536","EFO_0004192","HP_0030833","EFO_0004209","EFO_0000516","MONDO_0002258","EFO_1001434","EFO_0003785"],"count":43},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1961 and has 4 approved and 24 investigational indications."}
{"id":"CHEMBL63560","canonicalSmiles":"C[C@](O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1","inchiKey":"LKJPYSCBVHEWIU-KRWDZBQOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"(R)-BICALUTAMIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ICI-176334"],"crossReferences":{"PubChem":["144206041","144213865"],"Wikipedia":["Bicalutamide"],"drugbank":["DB02932"],"chEBI":["3090"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL66526","canonicalSmiles":"Cc1ccc(Cn2cnc(-c3cccs3)c2)cc1","inchiKey":"UMOFOLLUKPBVQG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL66526","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03030"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL730","canonicalSmiles":"O=[N+]([O-])OCC(CO[N+](=O)[O-])O[N+](=O)[O-]","inchiKey":"SNIOPGDIGTZGOP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"NITROGLYCERIN","yearOfFirstApproval":1981,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Coro-nitro","Deponit 10","Deponit 5","Glytrin","Gonitro","Lenitral 7.5","Minitran","Minitran 10","Minitran 15","Minitran 5","Natirose","Nitriderm tts","Nitro iv","Nitro-bid","Nitro-dur","Nitro-mack ret","Nitrocine","Nitrocontin continus","Nitroglycerin","Nitrol","Nitrolingual","Nitrolingual pumpspray","Nitromin","Nitromist","Nitronal","Nitrostat","Percutol","Rectiv","Rectogesic","Suscard buccal","Sustac","Transderm-nitro","Transiderm-nitro 10","Transiderm-nitro 5","Tridil","Trintek 10","Trintek 15","Trintek 5"],"synonyms":["C01DA02","Diluted nitroglycerin","Glyceryl Trinitrate","Glyceryl trinitrate","Nitroglycerin","Nitroglycerin tablets","Transderm-Nitro","Trinitrin tablets"],"crossReferences":{"DailyMed":["nitroglycerin"],"Wikipedia":["Nitroglycerin"],"drugbank":["DB00727"],"chEBI":["28787"]},"count":28,"approvedIndications":["EFO_0000319","EFO_0000612","EFO_0009552","EFO_0003843","EFO_0000537","EFO_0003913"],"linkedTargets":{"rows":["ENSG00000061918","ENSG00000123201"],"count":2},"linkedDiseases":{"rows":["EFO_0003086","EFO_0004234","EFO_1000657","EFO_0009846","HP_0031217","EFO_0003882","EFO_1001145","EFO_1000994","EFO_0003913","HP_0012390","HP_0000938","EFO_1000783","EFO_0000544","EFO_1001375","EFO_0003144","EFO_0000712","MONDO_0008903","EFO_1001993","EFO_0009552","EFO_0003917","EFO_0000685","MONDO_0005149","EFO_0002687","EFO_0001645","EFO_0000319","EFO_0003843","EFO_0003060","EFO_0000537","EFO_0000546","HP_0100806","MP_0001845","EFO_0008583","EFO_0000612","HP_0031273","MONDO_0004857","EFO_0004265","EFO_0005251"],"count":37},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1981 and has 6 approved and 22 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL772","canonicalSmiles":"COC(=O)[C@H]1[C@H]2C[C@@H]3c4[nH]c5cc(OC)ccc5c4CCN3C[C@H]2C[C@@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)[C@@H]1OC","inchiKey":"QEVHRUUCFGRFIF-MDEJGZGSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RESERPINE","yearOfFirstApproval":1960,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"]},"tradeNames":["Hiserpia","Rau-sed","Reserpine","Sandril","Serpalan","Serpanray","Serpasil","Serpate","Serpivite"],"synonyms":["ENT-50146","NSC-237659","NSC-59272","Reserpine"],"crossReferences":{"PubChem":["107574","144204658","144209593","144210855","170465405","17389743","26752948","50105550","50105551","50105552","50105553","56463068","90341213"],"Wikipedia":["Reserpine"],"drugbank":["DB00206"],"chEBI":["28487"]},"count":8,"approvedIndications":["EFO_0000537"],"linkedTargets":{"rows":["ENSG00000165646"],"count":1},"linkedDiseases":{"rows":["EFO_0003914","EFO_0001361","EFO_0002610","EFO_0003777","HP_0003124","EFO_0001645","EFO_0003763","EFO_0004701","EFO_0001360","EFO_0000537"],"count":10},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1960 and is indicated for hypertension and has 7 investigational indications. It was withdrawn in United States."}
{"id":"CHEMBL8600","canonicalSmiles":"COc1cc(CC(C)N)c(OC)cc1C","inchiKey":"NTJQREUGJKIARY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DOM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2-(2,5-Dimethoxy-4-Methyl-Phenyl)-1-Methyl-Ethylamine"],"crossReferences":{"drugbank":["DB01528"]},"childChemblIds":["CHEMBL558376","CHEMBL3247443"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL897","canonicalSmiles":"CCCN(CCC)S(=O)(=O)c1ccc(C(=O)O)cc1","inchiKey":"DBABZHXKTCFAPX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PROBENECID","yearOfFirstApproval":1951,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Benemid","Benuryl","Probalan","Probampicin","Probecid","Probenecid"],"synonyms":["HC 5006","NSC-18786","Probenecid"],"crossReferences":{"DailyMed":["probenecid"],"PubChem":["11112135","144203879","144209308","144213245","170464839","17389752","26747055","26747056","26751571","50100375","56424104","855953"],"Wikipedia":["Probenecid"],"drugbank":["DB01032"],"chEBI":["8426"]},"count":11,"approvedIndications":["EFO_0004274"],"linkedTargets":{"rows":["ENSG00000197901","ENSG00000168065","ENSG00000149452"],"count":3},"linkedDiseases":{"rows":["EFO_0000616","EFO_0003035","EFO_0004274","EFO_0005222","EFO_0001073","EFO_0003829","EFO_0003103","EFO_0000474","EFO_0000544","EFO_0003144","MONDO_0001314","EFO_0007328","EFO_1001207","MONDO_0043510","EFO_0001360"],"count":15},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1951 and is indicated for gout and has 10 investigational indications."}
{"id":"CHEMBL91238","canonicalSmiles":"CC(C)NNC(=O)COc1ccc(Cl)cc1","inchiKey":"GGECDTUJZOXAAR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IPROCLOZIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Iproclozide","PC-603"],"crossReferences":{"Wikipedia":["Iproclozide"],"drugbank":["DB09247"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL995","canonicalSmiles":"CCCCc1nc(Cl)c(CO)n1Cc1ccc(-c2ccccc2-c2nn[n-]n2)cc1.[K+]","inchiKey":"OXCMYAYHXIHQOA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"LOSARTAN POTASSIUM","yearOfFirstApproval":1995,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL191","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cozaar","Losaprex","Losartan potassium"],"synonyms":["Cozaar","DU PONT-753","DUP 753","DUP-753","E-3340","Hyzaar","L-158086","Losartan monopotassium salt","Losartan potassium","MK-0954","MK0954"],"crossReferences":{"DailyMed":["losartan%20potassium"],"PubChem":["49665951","49681581"]},"count":8,"approvedIndications":["EFO_0003086","EFO_0000537"],"linkedTargets":{"rows":["ENSG00000144891"],"count":1},"linkedDiseases":{"rows":["EFO_0002618","EFO_0003086","EFO_0000275","EFO_0003095","HP_0000093","MONDO_0002462","Orphanet_558","EFO_0000537","EFO_0004232","EFO_0003896","EFO_0002517","EFO_1002032","EFO_0001360","EFO_0000668"],"count":14},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1995 and is indicated for hypertension and kidney disease and has 6 investigational indications. This drug has a black box warning from the FDA."}
